Guardant Health AMEA is a joint venture between SoftBank and Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics.Cancer is data starved. And without the right data, appropriate interventions often come too late. To select the best treatment, doctors and patients must have access to detailed genomic information about the disease. But this information is not easy to get. Traditional tissue biopsies require physical access to tumor tissue and come with serious risks for some patients. And for many patients, they aren't even an option. In addition, they do little to help detect cancer early, when patients have the best chance at successful treatment.We believe the key to conquering cancer is unprecedented access to its molecular information throughout all stages of the disease. We are developing a solution through tests that require only a blood sample.